GlaxoSmithKline recently joined Pfizer in changing its continuing medical education granting process to eliminate medical education and communication companies as prospective grantees. In a press release on September 21, the company said that, beginning in 2010, it will be implementing new standards for its CME granting process that “will raise the bar and fund only independent medical education programs that are clearly designed to close gaps in patient care, and that demonstrate support ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only gain access to GSK Changing Its CME Granting Process, you'll get exclusive access to a large archive of premium content.

Already registered? here.